Labiotech.eu

Podcast 16 May 2025

Fighting mucopolysaccharidosis type I, a rare disease, by reprogramming B-cells

This week we talk with Immusoft CEO Sean Ainsworth to learn more about his journey in biotechnology and the work that Immusoft is doing in B-cell reprogramming

May 16, 2025

Expert Advice 15 May 2025

Expert tips to choose the right CDMO for your biotech company

Find out the best way to find the right CDMO for your biotech. Experts shared some advice to help companies through the process.

May 15, 2025 - 11 minutesmins - By Jules Adam

In Depth 14 May 2025

The stem cell race for Parkinson’s disease: Recent studies show significant promise

Discover how stem cells could be used to treat Parkinson’s disease, as positive early-stage studies in the field show significant promise.

May 14, 2025 - 8 minutesmins - By Willow Shah-Neville

Best in Biotech 13 May 2025

Nine biotech companies in Montreal to keep an eye on in 2025

Discover nine of the hottest biotech companies in Montreal that are advancing preclinical and clinical research.

May 13, 2025 - 11 minutesmins - By Roohi Mariam Peter

Cracking the code: Delivering biotherapeutics successfully across EMEA

Learn how to optimize cold chain logistics for biotherapeutics in EMEA and overcome key challenges in delivery and regulation.

May 13, 2025 - 8 minutesmins - By Will Chu

News and Trends 12 May 2025

Pharma giants pull back on AAV research: what’s next for the gene therapy space?

Biopharmas have been scaling back on AAV research for sometime now. Find out why and what’s on the horizon for drug delivery methods.

May 12, 2025 - 8 minutesmins - By Roohi Mariam Peter

In Depth 9 May 2025

The Netherlands’ biotech scene: The country sets its sights on becoming a global leader by 2040

With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global biotech leader.

May 9, 2025 - 8 minutesmins - By Willow Shah-Neville

Podcast 9 May 2025

Inside Flagship Pioneering’s strategy: How this VC turns ideas into biotech giants

In this episode Labiotech talks with Lovisa Afzelius, a General Partner at Flagship and uncovers the ways in which Flagship is shaking up the biotech funding model

May 9, 2025

In Depth 7 May 2025

Unlocking immunity: the power of TLR agonists

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

May 7, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 7 May 2025

Top biotech deals of April 2025

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and drug delivery.

May 7, 2025 - 9 minutesmins - By Roohi Mariam Peter

In Depth 6 May 2025

The future of diabetes treatment: Is a cure possible?

Diabetes has become an epidemic. Science is striving to find a diabetes treatment that can cure this chronic disease, but how close are we?

May 6, 2025 - 11 minutesmins - By Jules Adam

In Depth 5 May 2025

The biggest biotech funding rounds in April 2025

The companies Biohaven, MoonLake Immunotherapeutics, and AIRNA bagged the biggest biotech funding rounds overall in April 2025

May 5, 2025 - 4 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Fighting mucopolysaccharidosis type I, a rare disease, by reprogramming B-cells

Expert tips to choose the right CDMO for your biotech company

The stem cell race for Parkinson’s disease: Recent studies show significant promise

Nine biotech companies in Montreal to keep an eye on in 2025

Cracking the code: Delivering biotherapeutics successfully across EMEA

Pharma giants pull back on AAV research: what’s next for the gene therapy space?

The Netherlands’ biotech scene: The country sets its sights on becoming a global leader by 2040

Inside Flagship Pioneering’s strategy: How this VC turns ideas into biotech giants

Unlocking immunity: the power of TLR agonists

Top biotech deals of April 2025

The future of diabetes treatment: Is a cure possible?

The biggest biotech funding rounds in April 2025

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!